| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 2419 |
| 1 | FULVESTRANT | 2179 |
| 2 | LETROZOLE TABLETS | 1901 |
| 3 | RIBOCICLIB | 1825 |
| 4 | DENOSUMAB | 1807 |
| 5 | CAPECITABINE | 1336 |
| 6 | PALBOCICLIB | 1138 |
| 7 | ANASTROZOLE | 1099 |
| 8 | EVEROLIMUS | 1060 |
| 9 | PACLITAXEL | 1059 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTRAN 40 | 8 | 0.1111 |
| 1 | FULVESTRANT | 2179 | 0.0650 |
| 2 | RADIUM RA 223 DICHLORIDE | 327 | 0.0647 |
| 3 | RIBOCICLIB | 1825 | 0.0558 |
| 4 | GOSERELIN | 706 | 0.0520 |
| 5 | EXEMESTANE | 927 | 0.0431 |
| 6 | LETROZOLE TABLETS | 1901 | 0.0389 |
| 7 | LETROZOLE | 2419 | 0.0387 |
| 8 | CABAZITAXEL | 130 | 0.0370 |
| 9 | ANASTROZOLE TABLETS | 808 | 0.0368 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 3594 |
| 1 | Kinase Inhibitor [EPC] | 2602 |
| 2 | Estrogen Receptor Antagonist [EPC] | 2233 |
| 3 | RANK Ligand Inhibitor [EPC] | 1807 |
| 4 | Microtubule Inhibitor [EPC] | 1804 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 1563 |
| 6 | Corticosteroid [EPC] | 1318 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1159 |
| 8 | mTOR Inhibitor Immunosuppressant [EPC] | 1072 |
| 9 | Platinum-based Drug [EPC] | 1063 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 2233 | 0.0551 |
| 1 | Aromatase Inhibitor [EPC] | 3594 | 0.0315 |
| 2 | Androgen Receptor Inhibitor [EPC] | 898 | 0.0122 |
| 3 | Autologous Cellular Immunotherapy [EPC] | 67 | 0.0115 |
| 4 | Adrenal Steroid Synthesis Inhibitor [EPC] | 11 | 0.0110 |
| 5 | Microtubule Inhibitor [EPC] | 1804 | 0.0109 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 806 | 0.0108 |
| 7 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 193 | 0.0090 |
| 8 | RANK Ligand Inhibitor [EPC] | 1807 | 0.0089 |
| 9 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 5 | 0.0083 |